Intrapulmonary concentrations of pyrazinamide

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 6, 1999, Pages 1329-1333

  Conte Jr , John E ^a,b   Golden, Jeffrey A ^a   Duncan, Sheila ^a   McKenna, Elaine ^a   Zurlinden, Elisabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRAZINAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG PENETRATION; FEMALE; HUMAN; LUNG ALVEOLUS CELL; LUNG LAVAGE; LUNG TUBERCULOSIS; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0032996063     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.6.1329     Document Type: Article

References (29)

1. Acocella, G., N. A. Carlone, A. M. Cuffini, and G. Cavallo. 1985. The penetration of rifampicin, pyrazinamide, and pyrazinoic acid into mouse macrophages. Am. Rev. Respir. Dis. 131:1268-1273.
2. Acocella, G., A. Nonis, G. Perna, E. Patane, G. Gialdroni-Grassi, and C. Grassi. 1988. Comparative bioavailability of isoniazid, rifampin, and pyrazinamide. Am. Rev. Respir. Dis. 138:886-890.
3. Baldwin, D. R., R. Wise, J. M. Andrews, J. P. Ashby, and D. Honeybourne. 1990. Azithromycin concentrations at the sites of pulmonary infection. Eur. Respir. J. 3:886-890.
4. Baldwin, D. R., R. Wise, and D. Honeybourne. 1992. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob. Agents Chemother. 36:1171-1175.
5. Baldwin, D. R., D. Honeybourne, and R. Wise. 1992. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrob. Agents Chemother. 36:1176-1180.
6. Bareggi, S. R., R. Cerutti, R. Pirola, R. Riva, and M. Cisternino. 1987. Clinical pharmacokinetics and metabolism of pyrazinamide in healthy volunteers. Arzneimittelforschung 37:849-854.
7. Berning, S. E., G. A. Huitt, M. D. Iseman, and C. A. Peloquin. 1992. Malabsorption of antituberculosis medications by a patient with AIDS. N. Engl. J. Med. 327:1817-1818.
8. Carlone, N. A., G. Acocella, A. M. Cuffini, and M. Forno-Pizzoglio. 1995. Killing of macrophage-ingested mycobacteria by rifampicin, pyrazinamide, and pyrazinoic acid alone and in combination. Am. Rev. Respir. Dis. 132: 1274-1277.
9. Centers for Disease Control and Prevention. 1993. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 269:729-730.
10. Choudhri, S. H., M. Hawken, S. Gathua, G. O. Minyiri, W. Watkins, J. Sahal, D. S. Sitar, F. Y. Aoki, and R. Long. 1997. Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea. Clin. Infect. Dis. 25:104-111.
11. Conte, J. E., Jr., J. Golden, S. Duncan, E. McKenna, and E. Zurlinden. 1995. Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. Antimicrob. Agents Chemother. 39:334-338.
12. Conte, J. E., Jr., J. Golden, S. Duncan, E. McKenna, and E. Zurlinden. 1996. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cerfuroxime in volunteer subjects. Antimicrob. Agents Chemother. 40:1617-1622.
13. Conte, J. E., Jr., and J. Golden. 1995. Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 35:1166-1173.
14. Crowle, A. J., J. A. Sbarbaro, and M. H. May, 1986. Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages. Am. Rev. Respir. Dis. 134:1052-1055.
15. Gordon, S. M., C. R. Horsburgh, and C. A. Peloquin. 1993. Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. J. Infect. Dis. 168:1559-1562.
16. Heifits, L. 1988. Qualitative and quantitative drug-susceptibility tests in mycobacteriology. Am. Rev. Respir. Dis. 137:1217-1222.
17. Lacroix, C., T. P. Hoang, J. Nouveau, C. Guyonnaud, G. Laine, H. Duwoos, and O. Lafont. 1989. Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects. Eur. J. Clin. Pharmacol. 36:395-400.
18. National Center for Research Resources. 1997. PROPHET 5.0. National Center for Research Resources, National Institutes of Health, Bethesda, Md., and BBN Systems and Technologies, Cambridge, Mass.
19. Peloquin, C., G. Jaresko, C. L. Yong, A. Keung, A. Bulpitt, and R. Jelliffe. 1997. Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide. Antimicrob. Agents Chemother. 41:2670-2679.
20. Peloquin, C. A. 1993. Malabsorption of antimycobacterial medications. N. Engl. J. Med. 329:1122-1123.
21. Peloquin, C. A., A. T. Nitta, W. J. Burman, K. F. Brudney, J. R. Miranda-Massari, M. E. McGuinness, S. E. Berning, and G. T. Gerena. 1996. Low antituberculosis drug concentrations in patients with AIDS. Ann. Pharmacother. 30:919-925.
22. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J. Appl. Physiol. 60:532-538.
23. Sahai, J., K. Gallicano, L. Swick, S. Tailor, G. Garber, I. Seguin, L. Oliveras, S. Walker, A. Rachlis, and D. W. Cameron. 1997. Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection. Ann. Intern. Med. 127:289-293.
24. Salfinger, M., A. J. Crowle, and L. B. Reller. 1990. Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system. J. Infect. Dis. 162:201-207.
25. Salfinger, M., and L. B. Heifets. 1988. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob. Agents Chemother. 32:1002-1004.
26. Salfinger, M., L. B. Reller, B. Demchuk, and Z. T. Johnson. 1989. Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Res. Microbiol. 140:301-309.
27. Statistical Bulletin of the Metropolitan Life Foundation. 1983. 1983 Metropolitan height and weight tables. Stat. Bull. Metrop. Life Found. 64:3-9.
28. Talke, H., and G. E. Schubert. 1965. Enzymatische Harnstoffbestimmung im Blut und Serum im optischem Test nach Warburg. Klin. Wochenschr. 43: 174.
29. Wilcox, M., L. Kervitsky, C. Watters, and T. E. King. 1988. Quantification of cells recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 138:74-80.